Peptide Stack Calculator Guide: How to Plan a Multi-Compound Research Protocol

How to use the peptide stack calculator to plan a multi-compound research protocol — with worked examples for GHRP stacks, repair peptide combos, and GLP-1 protocols.

TL;DR — Peptide Stack Research at a Glance

• A peptide stack pairs compounds with complementary mechanisms — not redundant ones — to target multiple aspects of a research endpoint simultaneously
• The most well-validated research stacks pair a GHRH analog + GHRP for GH axis work, or BPC-157 + TB-500 for tissue repair
• Introduce one new compound at a time when building a stack to isolate variables and maintain clean research data
• Always reconstitute each compound separately and calculate doses independently before combining protocols
• Build and calculate your peptide stack now →

⚠️ Research Disclaimer: All peptides referenced in this guide are research compounds not approved by the FDA for human use. All information is for educational purposes only and does not constitute medical advice.

Building a peptide stack is one of the most nuanced decisions in peptide research protocol design. The concept sounds deceptively simple — combining multiple peptides into a single research protocol — but the pharmacological logic behind effective stacking requires a clear understanding of each compound's mechanism of action, receptor targets, half-life, and potential for interaction. A poorly constructed peptide stack either produces redundant, non-additive effects, introduces confounding variables that make results uninterpretable, or in the worst case creates receptor competition that blunts the effect of one or both compounds.

The peptide stack calculator lets you plan a full multi-compound protocol — doses, timing, and cycle length — in one view.

→ Open the Peptide Stack Calculator

The guide below covers how to use it and walks through the most common research stack combinations.

The Science of Peptide Stacking: Complementary Mechanisms vs Redundant Targets

Understanding why certain peptide stacks work requires a brief review of receptor biology and pathway architecture. Consider the GH axis: growth hormone release is governed by the interplay of two opposing signals — GHRH (stimulatory, acts at the GHRH receptor on pituitary somatotrophs) and somatostatin (inhibitory, limits GH pulse amplitude and frequency). A GHRH analog like CJC-1295 drives GH synthesis and amplifies pulse amplitude by acting at the GHRH receptor. A GHRP like Ipamorelin acts at the GHS-R1a receptor to trigger GH release AND suppress somatostatin tone, further disinhibiting the somatotrophs.

These two compounds act at separate receptors through separate intracellular mechanisms, and their effects on GH secretion are genuinely synergistic: the combined GH pulse from GHRH + GHRP co-administration is substantially larger than either compound alone at equivalent doses. This has been demonstrated experimentally in human volunteers (Bowers, 1998, Endocrine) and represents the gold standard of evidence for synergistic peptide stacking. The CJC-1295 and Ipamorelin stack research guide covers this specific combination in depth.

Contrast this with stacking two GHRPs — say, GHRP-6 and Hexarelin. Both act at GHS-R1a. They compete for the same receptor binding site, and combining them at standard doses does not reliably double GH output. From a research design standpoint, this combination also creates interpretation problems: which compound's downstream effects are you actually observing? Redundant stacks are thus poor experimental design as well as pharmacologically inefficient.

Goal-Based Peptide Stack Categories for Research

Recovery and Tissue Repair: BPC-157 + TB-500

The BPC-157 and TB-500 stack is one of the most widely studied peptide combinations in tissue repair research. The pairing is complementary at the mechanistic level: BPC-157 (Body Protection Compound-157) is a 15-amino acid gastric pentadecapeptide that promotes tendon-to-bone healing, stimulates fibroblast migration, and modulates the nitric oxide system to improve local vascularization. TB-500 (Thymosin Beta-4 synthetic analog) upregulates actin polymerization, promotes systemic cell migration and differentiation, and has demonstrated efficacy in wound healing models across multiple tissue types.

BPC-157 acts primarily at local tissue sites with a largely local mechanism; TB-500's actin-upregulation and cell-mobilization effects are more systemic. Together, they address tissue repair from complementary angles — local vascular and fibroblast promotion (BPC-157) combined with systemic mobilization of repair-competent cells and anti-inflammatory signaling (TB-500). BPC-157 is detailed in the BPC-157 complete research guide.

Growth Hormone Optimization: CJC-1295 + Ipamorelin

As discussed above, this is the most pharmacologically validated peptide stack in GH research. CJC-1295 (with or without DAC) drives amplitude of GH pulses via the GHRH receptor. Ipamorelin acts at GHS-R1a to trigger release and suppress somatostatin. The combination produces synergistically larger GH pulses than either compound alone and is the baseline GH axis research stack from which other combinations are evaluated.

Cognitive Research: Semax + Selank

For researchers investigating peptide nootropics and cognitive function, the Semax + Selank combination represents a well-reasoned approach to balanced cognitive modulation. Semax is an ACTH-derived heptapeptide that upregulates BDNF (Brain-Derived Neurotrophic Factor) expression and increases dopaminergic and serotonergic tone, producing stimulating, focus-enhancing effects. Selank is an anxiolytic peptide based on the immunomodulatory tetrapeptide tuftsin, which modulates GABA-ergic transmission and reduces anxiety without sedation. The stimulating effect of Semax combined with the anxiolytic balance of Selank creates a profile suited for cognitive performance research where anxiety-related confounding is a concern. Both compounds are covered in the peptide nootropics research section.

Body Composition Research: CJC-1295 + Ipamorelin + AOD-9604

Adding AOD-9604 to the CJC-1295 + Ipamorelin base stack creates a three-compound protocol targeting GH-related body composition endpoints. AOD-9604 is a fragment of the hGH molecule (amino acids 176–191) that retains the fat-metabolism activity of growth hormone without the mitogenic or anti-insulin effects of full GH. This three-way stack covers GH pulse stimulation (CJC + Ipamorelin) plus a targeted lipolytic signal (AOD-9604) that operates through a distinct pathway, making this a mechanistically sound combination for body composition research.

Longevity and Cellular Research: Epitalon + SS-31

Epitalon (Epithalon), a synthetic tetrapeptide based on the pineal gland's natural epithalamin, has been studied for its effects on telomerase activity and telomere maintenance, with research by Khavinson et al. published in Bulletin of Experimental Biology and Medicine demonstrating telomerase activation in human somatic cells. SS-31 (Szeto-Schiller peptide 31) is a mitochondria-targeting antioxidant peptide that concentrates in the inner mitochondrial membrane and reduces reactive oxygen species production. Together they represent a dual-target approach to cellular aging research: telomere biology (Epitalon) and mitochondrial oxidative stress (SS-31).

Peptide Stack Reference Table: Goal-Matched Compound Combinations

Peptide Stack Rules: How to Introduce and Monitor Multiple Compounds

The most important rule in building a peptide stack is to introduce one compound at a time. Begin with the primary compound of your stack, run a solo period of two to four weeks to establish baseline effects and confirm absence of unexpected responses, then add the second compound and observe for any changes attributable to the combination. This sequential introduction allows each compound's independent effects to be characterized before synergistic or antagonistic interactions complicate interpretation.

Keep detailed research logs: date, compound, dose, concentration (mcg/mL), syringe units drawn, injection site, time of day, and any notable observations. This documentation is essential for interpreting results and for troubleshooting if something unexpected occurs. Multi-compound stacks with documentation gaps are research failures — the data cannot be interpreted without knowing exactly what was administered when.

Start each new compound in a stack at the lower end of its research dose range and titrate upward based on observed response. A compound that is well-tolerated at 100 mcg solo may behave differently in the context of other active compounds. Lower starting doses when adding to an existing stack is standard conservative research practice.

Reconstitution Math for Two-Compound and Three-Compound Research Stacks

When running a peptide stack, each compound must be reconstituted separately — never combine lyophilized peptides in the same vial, and never mix two peptide solutions together before administration (unless a specific research protocol explicitly requires mixing). Each compound has its own optimal reconstitution solvent, concentration, and storage conditions.

For a two-compound stack (e.g., CJC-1295 DAC + Ipamorelin), you will have two separately reconstituted vials, each at a different concentration. Calculate and draw each dose independently using separate syringes, then administer each injection at different sites or combine volumes in the same syringe after drawing both separately — the latter approach is acceptable if both peptides are compatible (same solvent, similar pH, same storage conditions) and the combined volume remains practical for subcutaneous injection (generally under 0.5 mL per site).

Use the peptide reconstitution calculator to verify each compound's concentration and unit count. For multi-compound protocols, track total daily injection volume across all compounds to ensure no single site is receiving excessive volume per session.

How to Calculate Peptide Stack Doses Using Our Free Peptide Calculator

The free peptide dosage calculator is purpose-built for multi-compound research protocols. Enter each compound's vial size and BAC water volume to calculate concentration, then input your target dose for each. The calculator outputs syringe units for each compound independently and can display total daily dose and weekly dose summaries. For stacks where timing differs between compounds (e.g., Ipamorelin dosed twice daily while CJC-1295 DAC is dosed once weekly), the calculator tracks each compound's schedule separately. This tool eliminates the arithmetic errors that are the leading cause of dosing inconsistency in multi-compound research.

Frequently Asked Questions About Peptide Stacking

Q: Can you stack BPC-157 and TB-500 together? A: Yes — the BPC-157 and TB-500 stack is one of the most pharmacologically sound combinations in peptide research. The two compounds act through different mechanisms at different targets: BPC-157 promotes local vascularization and fibroblast activity, while TB-500 works systemically via actin upregulation and cell mobilization. Their mechanisms are complementary rather than competitive, and they have been studied together in several preclinical tissue repair models with results suggesting additive to synergistic efficacy at the tissue level.

Q: How many peptides can you stack at once in research protocols? A: There is no strict upper limit, but research validity and protocol management become increasingly difficult beyond three to four compounds. Each additional compound introduces another variable, another reconstitution workflow, another injection site requirement, and another potential source of receptor interaction. Most well-designed research stacks use two to three compounds with clearly distinct, non-competing mechanisms. Four-compound stacks are used in some body composition and recovery research contexts but require rigorous documentation to remain interpretable.

Q: Do peptides interfere with each other when stacked? A: Interference depends entirely on receptor overlap and pathway competition. GHRPs (Ipamorelin, GHRP-2, Hexarelin) all act at GHS-R1a and should generally not be combined because they compete for the same receptor. A GHRH analog (CJC-1295) and a GHRP (Ipamorelin) act at separate receptors and synergize. BPC-157 and TB-500 have no known receptor competition. Reviewing each compound's primary receptor target and downstream pathway before stacking is essential to identifying potential interference.

Q: Should you inject stacked peptides separately or mixed in the same syringe? A: The safest approach is always to inject each compound from a separately drawn syringe into a separately rotated site. Mixing two peptide solutions in the same syringe is pharmacologically acceptable when the compounds are dissolved in the same solvent type (both in BAC water, for example), the combined volume is practical, and no precipitation occurs visually — but mixing should be done in the barrel immediately before injection, not pre-mixed in the vial. Some researchers mix for convenience; strict research protocols use separate injections to eliminate any possibility of compound-compound interaction affecting the result.

Q: How do you use the peptide stack calculator to plan a multi-compound protocol? A: Navigate to the peptide dosage calculator and add each compound in your planned stack. For each, enter the vial size (mg), the volume of BAC water used for reconstitution, and your target dose (mcg or mg depending on the compound). The calculator generates the concentration, syringe unit count for each dose, and can display a dosing schedule if you input dosing frequency. Review the output to verify total daily injection volumes and confirm that individual site volumes remain below 0.5 mL, then save or print the protocol for your research log.

All content is for educational and research purposes only. Not medical advice.

Disclaimer: For educational and research purposes only. Nothing in this article constitutes medical advice, diagnosis, or treatment recommendation. All compounds discussed are research chemicals or investigational compounds unless explicitly noted otherwise. Consult a qualified healthcare professional before making any health-related decisions. Researchers must comply with all applicable laws and regulations in their jurisdiction.

Frequently Asked Questions